Helen Shih, MD
Radiation Oncology · Boston, MANPI 1346231248
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,920 of the $15,530 with a category attached, or 83.2%. Servier Pharmaceuticals LLC accounts for 83.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $10,198 and has fallen 81.9% since, to $1,845 in 2025. Among radiation oncology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $817.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Servier Pharmaceuticals LLC$13K
- Siemens Medical Solutions USA, Inc.$1K
- IBA Proton Therapy, Inc.$701
- Novocure Inc.$696
- Mevion_medical_systems_inc$8
Across 54 payments — averaging $2704.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$141K
- Servier Bioinnovation$4K
- Servier Pharmaceuticals LLC$1K
What the payments were for
- Consulting fees$12,92083%
- Travel & lodging$1,1347%
- Food & beverage$1,47610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Servier Pharmaceuticals LLC | 4 | $12,977 |
| Siemens Medical Solutions USA, Inc. | 6 | $1,149 |
| IBA Proton Therapy, Inc. | 2 | $701 |
| Novocure Inc. | 6 | $696 |
| Mevion_medical_systems_inc | 1 | $8 |
How this compares
$15,530 in reported general payments places this provider in the 90th percentile of 200 radiation oncology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Boston
- Peter OrioBoston$1.8M
- Paul NguyenBoston$721K
- Jason EfstathiouBoston$156K
- Jonathan SchoenfeldBoston$53K
- Martin KingBoston$37K
- Raymond MakBoston$36K
- Shannon MacdonaldBoston$33K
- Nima AghdamBoston$29K
- Rachel JimenezBoston$28K
- Theodore HongBoston$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.